Nicholas Chew
Overview
Explore the profile of Nicholas Chew including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
385
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee M, Febriana E, Lim M, Baig S, Shen L, Dalakoti M, et al.
Lancet Reg Health West Pac
. 2025 Jan;
54():101278.
PMID: 39840148
Background: Postprandial glucose concentration 1-h (1 h-PG) after an oral glucose tolerance test (OGTT) has similar or superior performance to 2 h-PG in predicting type-2 diabetes mellitus (T2DM) in several...
2.
Alebna P, Han C, Ambrosio M, Kong G, Cyrus J, Harley K, et al.
JACC Adv
. 2024 Dec;
3(12):101409.
PMID: 39640230
Background: Lipoprotein(a) [Lp(a)] is an independent risk factor for atherosclerotic cardiovascular disease. The relationship between Lp(a) and major adverse cardiovascular events (MACE) in the context of high-sensitivity C-reactive protein (hs-CRP)...
3.
Ngiam J, Chew N, Jou E, Ho J, Pramotedham T, Liong T, et al.
Singapore Med J
. 2024 Feb;
PMID: 38363650
Introduction: Patients with paradoxical low-flow (LF) severe aortic stenosis (AS) despite preserved left ventricular ejection fraction (LVEF) appear distinct from normal-flow (NF) patients, showing worse prognosis, more concentric hypertrophy and...
4.
Dalakoti M, Leow M, Khoo C, Yang H, Ling L, Muthiah M, et al.
Sci Rep
. 2023 Nov;
13(1):20521.
PMID: 37993612
Through extensive multisystem phenotyping, the central aim of Project PICMAN is to correlate metabolic flexibility to measures of cardiometabolic health, including myocardial diastolic dysfunction, coronary and cerebral atherosclerosis, body fat...
5.
Lim W, Lin S, Ng C, Tan D, Xiao J, Yong J, et al.
Hepatobiliary Surg Nutr
. 2023 Oct;
12(5):658-670.
PMID: 37886204
Background: Bariatric surgery represents an important treatment option for severely obese patients with nonalcoholic fatty liver disease (NAFLD). However, there remains inadequate data regarding the effects of different bariatric procedures...
6.
Chan K, Ong E, Chung C, Ong C, Koh B, Tan D, et al.
Clin Gastroenterol Hepatol
. 2023 Sep;
22(3):488-498.e14.
PMID: 37775028
Background & Aims: The progression of metabolic dysfunction-associated steatotic liver disease (MASLD) has been found to manifest in a series of hepatic and extrahepatic complications. A comprehensive meta-analysis of the...
7.
Weight N, Moledina S, Rashid M, Chew N, Castelletti S, Buchanan G, et al.
Int J Cardiol
. 2023 Aug;
391:131294.
PMID: 37625485
Background: The characteristics and risk factor profile of young patients presenting with non-ST segment elevation acute coronary syndrome (NSTEACS) and how they may have changed over time is not well...
8.
Xiao J, Ng C, Chan K, Fu C, Tay P, Yong J, et al.
J Clin Exp Hepatol
. 2023 Jul;
13(4):656-665.
PMID: 37440949
Background: Non-alcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease globally. While the prevalence, impact, and causes of mortality have been described in various meta-analyses, a systematic...
9.
Lim W, Tan C, Xiao J, Tan D, Ng C, Yong J, et al.
Liver Transpl
. 2023 Feb;
29(4):413-421.
PMID: 36724882
Post-transplant metabolic syndrome (PTMS) has been associated with increased cardiovascular risk which significantly impacts the morbidity and mortality rates of liver transplant (LT) recipients. This study sought to conduct a...
10.
Xiao J, Ng C, Chin Y, Tan D, Lim W, Lim G, et al.
J Clin Transl Hepatol
. 2022 Nov;
10(6):1042-1049.
PMID: 36381095
Background And Aims: Pharmaceutical therapy for NASH is associated with lipid modulation, but the consensus on drug treatment is limited and lacks comparative analysis of effectiveness. A network meta-analysis was...